Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis

Completed · Phase 3

Conditions studied: Psoriasis

In brief

The investigator's laboratory is studying a skin disease known as psoriasis. The purpose of this protocol is to study the action and the effects of Etanercept, on psoriasis. This medication has been studied extensively and has been found to be effective and safe in the treatment of psoriasis. The eligible patient will have 10% of his/her body surface area involved with psoriasis vulgaris. This trial is a phase III study to help understand the action of the drug etanercept, trade name Enbrel, for the adult patient with moderate to severe plaque psoriasis and who is a candidate for internal medications.

Key facts

Study ID

NCT00116181

Run by

Rockefeller University

People needed

30

Starts

2004-10-01

Last updated by the study team

2011-03-18

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Gender: Male and Female
• Minimum Age: 18
• Maximum Age: 70

You may not qualify if…

• Healthy Volunteers

Where it is running

• Rockefeller University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.